Skip to content

The prophylactic effect of adding magnesium to metoral in reducing coronary AF

Comparing the prophylactic effect of adding magnesium to Metoral in reducing atrial fibrillation after coronary artery bypass graft surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240527061915N1
Enrollment
102
Registered
2024-07-08
Start date
2024-06-21
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All CABG candidate patients referred to Amirul Mominin Hospital. Complications of cardiac and vascular prosthetic devices, implants and grafts

Interventions

Intervention 1: Intervention group: Metoral + magnesium (1-3 mg/kg) per hour Metoral equivalent to 3 cc and 2 g of menium equivalent to 4 cc are injected and (by 2 5 cc syringes). Intervention 2: Cont

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: All CABG candidate patients referred to Amirul Mominin Arak Hospital All patients candidates for elective operations The age of patients between 35-75 years All patients are candidates for CABG only All patients who are operated with that pump All patients with informed consent to participate in this study The average duration of surgery is maximum 7 hours All patients who do not have heart valve repair surgery with CABG ASA?,? patients Patients who are not allergic to Metoral-Magnesium All patients who have acid-base disorders resistant to treatment before surgery

Exclusion criteria

Exclusion criteria: Patients who suffer cardio-respiratory arrest during surgery Patients who do not agree to continue the study or cooperate All CABG candidate patients who require valve repair during surgery All patients who, after the induction of anesthesia, the surgeon decides to perform surgery with the pump OFF All patients who have acid-base disorders resistant to treatment before surgery

Design outcomes

Primary

MeasureTime frame
Occurrence of atrial fibrillation or other arrhythmias after surgery. Timepoint: 72 hours after the operation. Method of measurement: Monitoring and examination of patients will be used in open heart ICU.

Secondary

MeasureTime frame
Mortality and morbidity rate of patients. Timepoint: 72 hours after the operation. Method of measurement: Monitoring and examination of patients in open heart ICU.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Kamali

Arak University of Medical Sciences

AliKamaliir@yahoo.com+98 86 3417 3520

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026